Literature DB >> 2702657

Effect of organized screening on incidence and mortality of cervical cancer in Denmark.

E Lynge1, M Madsen, G Engholm.   

Abstract

Pap smears were used only on a limited scale in Denmark until the late 1960s. Since then smears have been taken both in organized screening programs and outside the programs by general practitioners, private gynecologists, and hospital wards. The present smear-taking activity is equivalent to an average of one smear every second year per woman. As the responsibility for health care rests with the counties in Denmark, differences are found between the counties both concerning organization of screening programs, and concerning the overall level of the smear-taking activity. An analysis using multiplicative Poisson models on county-based incidence and mortality data for women aged 30-59 years in 1963-1982 showed a statistically significant effect of organized screening in reducing both the incidence (RR = 0.67; 95% CI, 0.61-0.73), and the mortality (RR = 0.68; 95% CI, 0.59-0.78) of cervical cancer from 5 years after introduction of an organized screening program. The level of overall smear-taking activity was found to be of limited importance when organized screening was taken into account.

Entities:  

Mesh:

Year:  1989        PMID: 2702657

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  10 in total

Review 1.  Biomarkers as surrogates for cancer development.

Authors:  E Hawk; J L Viner; J A Lawrence
Journal:  Curr Oncol Rep       Date:  2000-05       Impact factor: 5.075

2.  Decreasing trend in mortality of chronic myelogenous leukemia patients after introduction of imatinib in Japan and the U.S.

Authors:  Dai Chihara; Hidemi Ito; Tomohiro Matsuda; Kota Katanoda; Akiko Shibata; Kumiko Saika; Tomotaka Sobue; Keitaro Matsuo
Journal:  Oncologist       Date:  2012-09-12

3.  Age-period-cohort analysis of cervical cancer incidence in Hong Kong from 1972 to 2001 using maximum likelihood and Bayesian methods.

Authors:  Gabriel M Leung; Pauline P S Woo; Sarah M McGhee; Annie N Y Cheung; Susan Fan; Oscar Mang; Thuan Q Thach; Hextan Y S Ngan
Journal:  J Epidemiol Community Health       Date:  2006-08       Impact factor: 3.710

4.  Cervical screening and health inequality in England in the 1990s.

Authors:  D Baker; E Middleton
Journal:  J Epidemiol Community Health       Date:  2003-06       Impact factor: 3.710

5.  Preliminary results of a general practice based call system for cervical cancer screening in The Netherlands.

Authors:  B T Palm; A C Kant; W J van den Bosch; G P Vooijs; C van Weel
Journal:  Br J Gen Pract       Date:  1993-12       Impact factor: 5.386

6.  Do Cervical Cancer Patients Diagnosed with Opportunistic Screening Live Longer? An Arkhangelsk Cancer Registry Study.

Authors:  Elena E Roik; Evert Nieboer; Olga A Kharkova; Andrej M Grjibovski; Vitaly A Postoev; Jon Ø Odland
Journal:  Int J Environ Res Public Health       Date:  2017-11-26       Impact factor: 3.390

7.  Cytologic screening for cancer of the uterine cervix in Sweden evaluated by identification and simulation.

Authors:  L Gustafsson; H O Adami
Journal:  Br J Cancer       Date:  1990-06       Impact factor: 7.640

8.  Efficiency of organised and opportunistic cytological screening for cancer in situ of the cervix.

Authors:  L Gustafsson; P Sparén; M Gustafsson; E Wilander; R Bergström; H O Adami
Journal:  Br J Cancer       Date:  1995-08       Impact factor: 7.640

9.  Impact of the introduction of organised screening for cervical cancer in Turin, Italy: cancer incidence by screening history 1992-98.

Authors:  G Ronco; S Pilutti; S Patriarca; G Montanari; B Ghiringhello; R Volante; L Giordano; R Zanetti; E Mancini; N Segnan
Journal:  Br J Cancer       Date:  2005-08-08       Impact factor: 7.640

10.  Cervical cancer screening programmes and policies in 18 European countries.

Authors:  A Anttila; G Ronco; G Clifford; F Bray; M Hakama; M Arbyn; E Weiderpass
Journal:  Br J Cancer       Date:  2004-08-31       Impact factor: 7.640

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.